buparvaquone has been researched along with plumbagin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Danilenko, NV; Karpenko, AS; Khlebnikov, AI; Kirpotina, LN; Levandovskiy, IA; Quinn, MT; Schepetkin, IA; Shibinska, MO | 1 |
Croft, SL; Luque-Ortega, JR; Rivas, L; Rivero-Lezcano, OM | 1 |
2 other study(ies) available for buparvaquone and plumbagin
Article | Year |
---|---|
Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
Topics: Antineoplastic Agents; cdc25 Phosphatases; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Humans; MAP Kinase Kinase 7; Models, Molecular; Molecular Docking Simulation; Naphthoquinones | 2019 |
In vivo monitoring of intracellular ATP levels in Leishmania donovani promastigotes as a rapid method to screen drugs targeting bioenergetic metabolism.
Topics: Adenosine Triphosphate; Animals; Antiprotozoal Agents; Cell Division; Cell Line; Dose-Response Relationship, Drug; Energy Metabolism; Firefly Luciferin; Kinetics; Leishmania donovani; Luciferases; Luminescent Measurements; Membrane Potentials; Mitochondria; Naphthoquinones; Parasitic Sensitivity Tests; Transfection | 2001 |